Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Retrotherapy LLC
Profile last edited on: 11/25/16      CAGE: 47JC6      UEI:

Business Identifier: Research on gene expression
Year Founded
2004
First Award
2010
Latest Award
2015
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4519 Gretna Street
Bethesda, MD 20814
   (301) 503-1202
   N/A
   www.retrotherapy.biz
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

RetroTherapy is developing new technologies to better control gene expression. These may help speed the development of stem cell therapies. RetroTherapy was the first company to win an award from the Maryland Stem Cell Research Fund. The firm is engaged in research to restrict production of progeria.

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$1,345,315
Phase II Dollars
$0
Total Awarded
$1,345,315

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2015 1 NIH $226,921
Project Title: Optimizing Correction of the Huntington's Disease Mutation by Trans-Splicing
2014 1 NIH $225,000
Project Title: Correcting Aberrant Splicing of the Human Cd22 Gene
2011 1 NIH $521,305
Project Title: Development Of Tools To Modify Globin Gene Expression In Stem Cells
2010 1 NIH $372,089
Project Title: Optimization Of A Method To Reduce Expression Of Progerin, The Cause Of Hgps (Pro

Key People / Management

  Lloyd G Mitchell -- Chief Executive Officer

Company News

There are no news available.